Regeneron Pharmaceuticals
REGN
REGN
1,301 hedge funds and large institutions have $89.1B invested in Regeneron Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 479 increasing their positions, 448 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 25 → 25 (0)
0.16% less ownership
Funds ownership: 86.33% → 86.17% (-0.16%)
40% less call options, than puts
Call options by funds: $971M | Put options by funds: $1.63B
Holders
1,301
Holding in Top 10
25
Calls
$971M
Puts
$1.63B
Top Buyers
| 1 | +$1.16B | |
| 2 | +$482M | |
| 3 | +$459M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$229M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$213M |
Top Sellers
| 1 | -$904M | |
| 2 | -$458M | |
| 3 | -$268M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$198M |
| 5 |
D.E. Shaw & Co
New York
|
-$129M |